Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 221

1.

Histamine H3-receptor inverse agonists as novel antipsychotics.

Ito C.

Cent Nerv Syst Agents Med Chem. 2009 Jun;9(2):132-6. Review.

PMID:
20021346
[PubMed - indexed for MEDLINE]
2.

Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.

Esbenshade TA, Fox GB, Krueger KM, Baranowski JL, Miller TR, Kang CH, Denny LI, Witte DG, Yao BB, Pan JB, Faghih R, Bennani YL, Williams M, Hancock AA.

Biochem Pharmacol. 2004 Sep 1;68(5):933-45.

PMID:
15294456
[PubMed - indexed for MEDLINE]
3.

Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.

Yates SL, Phillips JG, Gregory R, Pawlowski GP, Fadnis L, Khan MA, Ali SM, Tedford CE.

J Pharmacol Exp Ther. 1999 May;289(2):1151-9.

PMID:
10215699
[PubMed - indexed for MEDLINE]
Free Article
4.

[The histamine H3 receptor: a new target for the treatment of arousal and cognitive disorders].

Arrang JM.

Ann Pharm Fr. 2007 Jul;65(4):275-84. Review. French.

PMID:
17652997
[PubMed - indexed for MEDLINE]
5.

Lack of cataleptogenic potentiation with non-imidazole H3 receptor antagonists reveals potential drug-drug interactions between imidazole-based H3 receptor antagonists and antipsychotic drugs.

Zhang M, Ballard ME, Pan L, Roberts S, Faghih R, Cowart M, Esbenshade TA, Fox GB, Decker MW, Hancock AA, Rueter LE.

Brain Res. 2005 May 31;1045(1-2):142-9. Epub 2005 Apr 20.

PMID:
15910772
[PubMed - indexed for MEDLINE]
6.

The role of histaminergic H1 and H3 receptors in food intake: a mechanism for atypical antipsychotic-induced weight gain?

Deng C, Weston-Green K, Huang XF.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Feb 1;34(1):1-4. doi: 10.1016/j.pnpbp.2009.11.009. Epub 2009 Nov 14. Review.

PMID:
19922755
[PubMed - indexed for MEDLINE]
7.

Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.

Hey JA, Aslanian R, Bolser DC, Chapman RW, Egan RW, Rizzo CA, Shih NY, Fernandez X, McLeod RL, West R, Kreutner W.

Arzneimittelforschung. 1998 Sep;48(9):881-8.

PMID:
9793613
[PubMed - indexed for MEDLINE]
8.

GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models.

Medhurst AD, Atkins AR, Beresford IJ, Brackenborough K, Briggs MA, Calver AR, Cilia J, Cluderay JE, Crook B, Davis JB, Davis RK, Davis RP, Dawson LA, Foley AG, Gartlon J, Gonzalez MI, Heslop T, Hirst WD, Jennings C, Jones DN, Lacroix LP, Martyn A, Ociepka S, Ray A, Regan CM, Roberts JC, Schogger J, Southam E, Stean TO, Trail BK, Upton N, Wadsworth G, Wald JA, White T, Witherington J, Woolley ML, Worby A, Wilson DM.

J Pharmacol Exp Ther. 2007 Jun;321(3):1032-45. Epub 2007 Feb 27.

PMID:
17327487
[PubMed - indexed for MEDLINE]
Free Article
9.

Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.

Lim HD, van Rijn RM, Ling P, Bakker RA, Thurmond RL, Leurs R.

J Pharmacol Exp Ther. 2005 Sep;314(3):1310-21. Epub 2005 Jun 9.

PMID:
15947036
[PubMed - indexed for MEDLINE]
Free Article
10.

Modulation of neurotransmitter release via histamine H3 heteroreceptors.

Schlicker E, Malinowska B, Kathmann M, Göthert M.

Fundam Clin Pharmacol. 1994;8(2):128-37. Review.

PMID:
8020871
[PubMed - indexed for MEDLINE]
11.

Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats.

Blandina P, Giorgetti M, Bartolini L, Cecchi M, Timmerman H, Leurs R, Pepeu G, Giovannini MG.

Br J Pharmacol. 1996 Dec;119(8):1656-64.

PMID:
8982515
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Molecular imaging of histamine receptors in the human brain].

Tashiro M, Yanai K.

Brain Nerve. 2007 Mar;59(3):221-31. Review. Japanese.

PMID:
17370648
[PubMed - indexed for MEDLINE]
13.

The role of the central histaminergic system on schizophrenia.

Ito C.

Drug News Perspect. 2004 Jul-Aug;17(6):383-7. Review.

PMID:
15334189
[PubMed - indexed for MEDLINE]
14.

Histamine-selective H3 receptor ligands and cognitive functions: an overview.

Vohora D.

IDrugs. 2004 Jul;7(7):667-73. Review.

PMID:
15243869
[PubMed - indexed for MEDLINE]
15.

Histamine and schizophrenia.

Arrang JM.

Int Rev Neurobiol. 2007;78:247-87. Review.

PMID:
17349864
[PubMed - indexed for MEDLINE]
16.

Emedastine: a potent, high affinity histamine H1-receptor-selective antagonist for ocular use: receptor binding and second messenger studies.

Sharif NA, Su SX, Yanni JM.

J Ocul Pharmacol. 1994 Winter;10(4):653-64.

PMID:
7714409
[PubMed - indexed for MEDLINE]
17.

Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.

Sadek B, Elz S, Pertz HH, Stark H, Schunack W.

Inflamm Res. 2004 Aug;53 Suppl 2:S109-15. Epub 2004 Aug 10.

PMID:
15338060
[PubMed - indexed for MEDLINE]
18.

Development of trans-2-[1H-imidazol-4-yl] cyclopropane derivatives as new high-affinity histamine H3 receptor ligands.

Tedford CE, Phillips JG, Gregory R, Pawlowski GP, Fadnis L, Khan MA, Ali SM, Handley MK, Yates SL.

J Pharmacol Exp Ther. 1999 May;289(2):1160-8.

PMID:
10215700
[PubMed - indexed for MEDLINE]
Free Article
19.

Histamine H3 antagonists as wake-promoting and pro-cognitive agents.

Stocking EM, Letavic MA.

Curr Top Med Chem. 2008;8(11):988-1002. Review.

PMID:
18673168
[PubMed - indexed for MEDLINE]
20.

Autoregulation of McA-RH7777 hepatoma cell proliferation by histamine H3 receptors.

Davenas E, Rouleau A, Morisset S, Arrang JM.

J Pharmacol Exp Ther. 2008 Aug;326(2):406-13. doi: 10.1124/jpet.107.135368. Epub 2008 May 12.

PMID:
18474684
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk